Use our Pill Identifier tool to instantly match by imprint, shape, color, drug name, or NDC code. Access over 11,500 drug images, updated daily.
How to identify a pill using the Pill Identifier? Enter the imprint code that appears on the pill, example: L484 Select the pill color (optional). Select the shape (optional). Alternatively, search by drug name or NDC code using the fields below....
The RxList Pill Identifier Tool will help you identify prescription, over-the-counter (OTC), generic, and brand name drugs by pill color, size, shape, and drug imprint. Match your drug imprint (Pill ID) to the pictures and quickly identify your medications. If you do not find a match,...
The RxList Pill Identifier Tool will help you identify prescription, over-the-counter (OTC), generic, and brand name drugs by pill color, size, shape, and drug imprint. Match your drug imprint (Pill ID) to the pictures and quickly identify your medications. If you do not find a match,...
The RxList Pill Identifier Tool will help you identify prescription, over-the-counter (OTC), generic, and brand name drugs by pill color, size, shape, and drug imprint. Match your drug imprint (Pill ID) to the pictures and quickly identify your medications. If you do not find ...
9Clinicaltrials.gov. A study of JNJ-2113 for the treatment of participants with plaque psoriasis involving special areas (scalp, genital, and/or palms of the hands and the soles of the feet) (ICONIC-...
The http://www.clinicaltrials.gov identifier is NCT01480635. All patients included in the study were 18 years or older who had incomplete colonoscopies that were performed by an experienced endoscopist (> 1000 colonoscopies performed). Incomplete OC was defined as a failure to reach the cecum ...
The EudraCT identifier was 2009-016693-33, ClinicalTrials.gov identifier NCT01113047.Results:Of the 187 patients not adequately controlled in phase 1 and thus treated with the SPC aliskiren 300/amlodipine 10 in phase 2, 69 were of advanced age (≥65 years), 74 or 89 were overweight or ...
The EudraCT identifier was 2009-016693-33, ClinicalTrials.gov identifier NCT01113047.Results:Of the 187 patients not adequately controlled in phase 1 and thus treated with the SPC aliskiren 300/amlodipine 10 in phase 2, 69 were of advanced age (≥65 years), 74 or 89 were overweight or ...
Conclusions and Relevance Among Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieved better blood pressure lowering and control with good tolerability compared with the standard-care protocol. Trial Registration Pan African Clinical Trials Registry Identifier:PACTR...